The short answer
The FDA label for Depo-Testosterone (testosterone cypionate injection) gives one dose range for adult men on replacement therapy: 50 to 400 mg every two to four weeks, injected deep into the gluteal muscle. Before starting, low testosterone should be confirmed with morning blood tests on at least two separate days. Once you are on it, the label asks for two things to be watched over time: hemoglobin and hematocrit (to catch thickened blood), and blood pressure.
Your prescriber sets your dose and schedule. This article walks through what the label itself says, so you know what the numbers on your vial mean and what to ask at your next appointment. Everything below comes from the current Depo-Testosterone label on DailyMed (DailyMed, Depo-Testosterone label, revised June 2025) unless another source is linked.
Who the label is for
Testosterone cypionate is approved as replacement therapy in men whose bodies make little or no testosterone. The label is direct about one limit: safety and efficacy in men with "age-related hypogonadism" (also called late-onset hypogonadism) have not been established. In other words, low testosterone that comes only with getting older is not what the approval covers.
Before the first shot, the label says the diagnosis should be confirmed by measuring serum testosterone in the morning on at least two separate days, with both results below the normal range. One low reading is not enough.
The approved dose range
The label's dosing for replacement in men is a single sentence: 50 to 400 mg every two to four weeks. That is a wide range on purpose. The label says dosage is adjusted according to each patient's response and to any side effects that show up.
The label also lists who should not use it, including men with known or suspected prostate cancer, men with breast cancer, women who are pregnant, and people with serious heart, liver or kidney disease.
It also notes that testosterone is a Schedule III controlled substance, and that misuse usually involves doses higher than the approved ones.
Reading your vial: mg versus mL
Depo-Testosterone comes in two strengths (DailyMed, How Supplied):
- 100 mg/mL in a 10 mL multiple-dose vial
- 200 mg/mL in a 1 mL single-dose vial or a 10 mL multiple-dose vial
Your prescription is written in milligrams, but you draw up milliliters, so the strength on the label matters. The math is one division: mg prescribed divided by mg per mL equals mL to draw. For example, a 100 mg dose is 0.5 mL from a 200 mg/mL vial but 1 mL from a 100 mg/mL vial. If your pharmacy switches strengths between fills, the volume you draw changes even though your dose does not. Check the strength on every new vial.
Storage and crystals
The label says to store vials at room temperature, 20 to 25 C (68 to 77 F), and to protect them from light. Cold storage can cause crystals to form in the oil. The label says warming and shaking the vial should redissolve them. It also says to look at the solution for particles or discoloration before each injection.
The blood tests the label asks for
Hemoglobin and hematocrit. The label says these should be checked periodically in people on long-term androgen therapy, to detect polycythemia. Polycythemia means too many red blood cells, which makes the blood thicker. The label does not give a set schedule, so ask your prescriber how often they want this drawn.
Cholesterol. The label notes that serum cholesterol may rise during androgen therapy.
Testosterone level. The label mentions checking serum testosterone if misuse is suspected, to see whether levels are in the therapeutic range. Routine level checks and their timing are set by your prescriber.
Keeping each result next to the date of your last injection makes these numbers much easier to read, because a level drawn two days after a shot and one drawn the day before your next shot can differ.
Blood pressure: the newest label change
On February 28, 2025, the FDA announced class-wide labeling changes for testosterone products (FDA, class-wide labeling changes for testosterone products). Two parts matter here:
- The FDA required a blood pressure warning on testosterone products that did not already have one.
- It recommended removing language from the Boxed Warning about an increased risk of adverse heart outcomes, based on the TRAVERSE trial.
The Depo-Testosterone label now reads that testosterone can increase blood pressure, which can raise cardiovascular risk over time. It says to monitor blood pressure periodically, especially in men with high blood pressure, and that testosterone products are not recommended for people whose high blood pressure is uncontrolled.
What the TRAVERSE trial found
TRAVERSE enrolled 5,246 men aged 45 to 80 with low testosterone symptoms and existing heart disease or high heart risk (Lincoff et al., NEJM 2023, PubMed 37326322). Men used a daily testosterone gel or a placebo gel. Major heart events (heart attack, stroke or heart-related death) happened in 7.0% of the testosterone group and 7.3% of the placebo group, which met the trial's test for noninferiority.
Two details are worth knowing. First, TRAVERSE used a gel, not injections. Second, the testosterone group had more atrial fibrillation, acute kidney injury and pulmonary embolism than the placebo group. The Depo-Testosterone label still says long-term trials of cardiovascular outcomes have not been conducted for testosterone replacement therapy in men.
Warning signs to report
The label asks patients to report nausea, vomiting, changes in skin color, ankle swelling, and erections that happen too often or last too long.
It also describes blood clots reported with testosterone products. The label says pain, swelling, warmth or redness in a lower leg should be checked for a deep vein clot, sudden shortness of breath should be checked for a clot in the lung, and testosterone should be stopped if a clot is suspected. Get medical help right away for either.
Making the routine easier to follow
Testosterone cypionate is simple on paper and easy to lose track of in practice: an injection every few weeks, two possible vial strengths, and lab work that only makes sense next to your shot dates. A log that keeps all of this in one place helps you spot patterns before your appointment.
If you want an app for that, the Dose Track TRT tracker logs injections, symptoms and lab results on one timeline. You can also compare notes with other people on TRT in the Dose Track Community.
This article is general information from the FDA label and published research, not medical advice. Your prescriber decides your dose, schedule and lab plan.

